(All times are in Central Standard Time)
|
|
12:00 – 1:30 pm |
Prevention Special Session: Mechanisms of Obesity Related Risk for Breast Cancer and Approaches to Risk Reduction
Moderator: Carol Fabian, University of Kansas Medical Center, Westwood, Kansas
- Lifestyle, Genetic, and Epigenetic Interactions in Predicting Development of Obesity and Response to Calorie Restriction and Physical Activity
Catherine Duggan, Fred Hutch Cancer Center, Seattle, Washington
- Achieving Sufficient Fat loss and Metabolic Improvement to Reduce Cancer Risk:
Newer Generation GLP-1n and GIP Receptor Agonists (NUSH-Based Therapeutics)
Neil Iyengar, Memorial Sloan Kettering Cancer Center
- Impact and Types of Exercise and Pharmacotherapy in Weight Loss
John Jakicic, University of Kansas Medical Center, Westwood, Kansas
- Panel Discussion
|
12:00 – 1:45 |
Career Development: Navigating the Road to Success – Early Funding for Research and Beyond
Moderator: Brenda Ernst, Mayo Clinic Comprehensive Cancer Center, Phoenix, Arizona
- Federal Funding Opportunities
Oliver Bogler, National Cancer Institute, Bethesda, Maryland
- Foundation Funding
Sara Tolaney, Daba-Farber Cancer Institute, Boston, Massachusetts
- Interactions with Industry
Minetta Liu, Natera, Austin, Texas
- Panel Discussion
|
12:00 – 1:45 pm |
FDA Special Session: New Drug Approvals |
12:00 – 1:45 pm |
Special Session 3: Sex, Drugs, Rock and Roll
Moderator: Christine Ambrosone, Roswell Park Comprehensive Cancer Center, Buffalo, New York
Patient Advocate: Tomika Bryant, King of Prussia, Pennsylvania
- Supplements and Cannabis
Heather Greenlee, Fred Hutch Cancer Center, Seattle, Washington
- Sexual Health
Don Dizon, Legorreta Cancer Center at Brown University/Lifespan Cancer Institute, Providence, Rhode Island
- Exercise During Treatment
Rikki Cannioto, Roswell Park Comprehensive Cancer Center, Buffalo, New York
- Alcohol
Marilyn Kwan, Kaiser Permanente Northern California, Pleasanton, California
- Panel Discussion
|
2:00 – 3:45 pm |
Clinical Workshop: Dose Optimization in Breast Medical Oncology |
2:00 – 3:45 pm
|
Translational Workshop: Cancer Immunology Discovery Approaches into Clinical Trials
Moderator: Christine Desmedt, KU Leuven, Leuven, Belgium
- Multiplex Imaging for Precision Oncology
Raza Ali, Cancer Research UK, Cambridge, United Kingdom
- Single Cell T-Cell Receptors and B-Cell Receptors
Diether Lambrechts, Catholic University of Leuven, Leuven, Belgium
- Spatial Transcriptomics
Christos Sotiriou, Institut Jules Bordet, Brussels, Belgium
- Cancer Immunology Discovery Approaches into Clinical Trials
Emanuela Romano, Institut Curie, Paris, France
- Panel Discussion
|
4:00 – 5:45 pm
|
Educational Session 1: Mind the Gap — Breast Cancer in the Young
Moderator: Matteo Lambertini, University of Genova - IRCCS Ospedale Policlinico San Martino, Genoa, Italy
Patient Advocate: Na'Diah Smith, Dallas, Texas
- Biology of Breast Cancer in Young Women
Camila Dos Santos, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
- Ovarian Suppression - Who, When, Why, and for How Long
Prudence Francis, Peter MacCallum Cancer Centre, Melbourne, Australia
- Survivorship
Jennifer Sheng, Johns Hopkins University, Baltimore, Maryland
- Panel Discussion
|
4:00 – 5:45 pm
|
Educational Session 2: Liquid Biopsy: MRD, CT DNA, and Monitoring Response to Treatment
Moderator: Moderator: Adrian Lee, University of Pittsburgh, Pittsburgh, Pennsylvania
Patient Advocate: Ellen Landsberger, New York City
- Review of Current Technologies
Heather Parsons, Dana-Farber Cancer Institute, Boston, Massachusetts
- Early Detection and Molecular Recurrent Disease
Ben Park, Vanderbilt University Medical Center, Nashville, Tennessee
- Utility in the Metastatic Setting
David Cescon, UHN Princess Margaret Cancer Centre, Toronto, Canada
- Panel Discussion
|
4:00 – 5:45 pm
|
Educational Session 3: Tumor Heterogeneity and Evolution
Moderator: Reuben S. Harris, UT Health San Antonio, San Antonio, Texas
- Therapy Induced Evolution
Nicholas Navin, UT MD Anderson Cancer Center, Houston, Texas
- Genomic and Microenvironment Determinants of Breast Cancer Progression
Christina Curtis, Stanford University, Stanford, California
- Single Cell Genomics in Triple Negative Breast Cancer
Ashley Laughney, Weill Cornell Medicine, New York, New York
- Panel Discussion
|
4:00 – 5:45 pm
|
Educational Session 4: Optimizing Early HER2 Positive Breast Cancer Treatment
Moderator: Javier Cortes, International Breast Cancer Center, Barcelona, Spain
Patient Advocate: Thelma Brown, Birmingham, Alabama
- Neoadjuvant Management and Adaptive Strategies
Gabe Sonke, Netherlands Cancer Institute, Amsterdam, Netherlands
- Treatment of Small Tumors in Early-Stage Setting
Adrienne Waks, Dana-Farber Cancer Institute, Boston, Massachusetts
- Post Neoadjuvant Management for non pCR
Joyce O'Shaughnessy, Baylor Charles A. Sammons Cancer Center, Dallas, Texas
- Panel Discussion
|
5:45 – 6:15 pm |
Refreshment and Networking Break |
6:00 – 7:00 pm |
Late Breaking Oral Presentations |